Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor.
Characteristics in childhood and adolescence associated with future multiple sclerosis risk in men: cohort study.
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy.
[Antioxidant use as dietary therapy in patients with multiple sclerosis].
Detecting deoxyhemoglobin in spinal cord vasculature of the experimental autoimmune encephalomyelitis mouse model of multiple sclerosis using susceptibility MRI and hyperoxygenation.
Degradation of polyomavirus JC T-antigen by stress involves the LIP isoform of C/EBP.
Variant of multiple sclerosis with dementia and tumefactive demyelinating brain lesions.
Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.
Indoles mitigate the development of experimental autoimmune encephalomyelitis by induction of reciprocal differentiation of regulatory T cells and Th17 cells.
Local dynamic stability as a responsive index for the evaluation of rehabilitation effect on fall risk in patients with multiple sclerosis: a longitudinal study.
Analysis of symptoms, functional impairments, and participation in occupational therapy for individuals with multiple sclerosis.
The impact of diagnostic criteria for neuromyelitis optica in patients with MS: a 10-year follow-up of the South Atlantic Project.
Neuroimmunology: Aquaporin-4-antibody-seronegative neuromyelitis optica is less common than previously thought.
T cell-activation in neuromyelitis optica lesions plays a role in their formation.
Cross-validation of oxygen uptake prediction during walking in ambulatory persons with multiple sclerosis.
The Standards of Reporting of Neurological Disorders (STROND) checklist: Application to multiple sclerosis.
The Role of Pregnancy-Associated Hormones in the Development and Function of Regulatory B Cells.
A GPBAR1 (TGR5) Small Molecule Agonist Shows Specific Inhibitory Effects on Myeloid Cell Activation In Vitro and Reduces Experimental Autoimmune Encephalitis (EAE) In Vivo.
The choroid plexus is modulated by various peripheral stimuli: implications to diseases of the central nervous system.
New acoustic wave therapy improves quality of life in patients with multiple sclerosis and chronic cerebrospinal venous insufficiency.
Endogenous Two-Photon Excited Fluorescence Provides Label-Free Visualization of the Inflammatory Response in the Rodent Spinal Cord.
Insulator Protein Helps Organize the Gaps in the Axon's Insulation.
[Blood and cerebrospinal fluid test in multiple sclerosis].
[Current Status of Genetic Diagnosis of Charcot-Marie-Tooth Disease: Variety of the Disease-causing Genes].
Optical Coherence Tomography for the Detection of Remote Optic Neuritis in Multiple Sclerosis.
Pages
« first
‹ previous
…
533
534
535
536
537
538
539
540
541
…
next ›
last »